Log In
Print
BCIQ
Print
Print this Print this
 

NEO-102

  Manage Alerts
Collapse Summary General Information
Company Precision Biologics Inc.
DescriptionChimeric mAb targeting a variant of mucin 5AC oligomeric mucus/gel-forming (MUC5AC)
Molecular Target Mucin 5AC oligomeric mucus/gel-forming (MUC5AC)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today